Toggle menu

DASH

Start date:
June 2019

Why?

Medications to ‘thin’ the blood can have an unwanted effect on strokes caused by bleeding in the brain. Controlling bleeding is crucial in the first few hours after stroke but there is still uncertainty over the best course of treatment.

 

What?

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.

 

https://clinicaltrials.gov/ct2/show/NCT03696121

Research Team

Allan MacRaild

Stroke Lead Research Nurse

Seona Burgess

Senior Stroke Research Nurse

Pat Taylor

Senior Stroke Research Nurse

Rachel O'Brien

Lead Research Nurse

Julia Grahamslaw

Lead Research Nurse

Fiona McCurrach

Senior Research Nurse

More EMERGE Trials

Evaluating the role of early CT Coronary Angiography on patients with suspected or confirmed Acute Coronary Syndrome.

Read more

RAPID-CTCA

Evaluating the role of early CT Coronary Angiography

Attitudes towards Research and Research Nurses among the clinical team in an Emergency Department (ED) and Acute Medical Unit (AMU)

Read more

Research on Research

Attitudes towards Research and Research Nurses

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)